Zimmer Biomet Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Zimmer Biomet Holdings (ZBH).

Price Target Range — 11 Quarters

Analyst Consensus — 23 Analysts

2S.Buy

8Buy

13Hold

Consensus RatingNeutral# Analysts23Avg. Consensus PT$107Upside to Avg. PT+13.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 22, 2026	Argus Research	David Toung	Maintained	Buy	$125
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Equal-Weight	$100
Aug 10, 2026	Canaccord Genuity	Caitlin Roberts	PT Raise	Hold	$83→$100
Aug 7, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$92→$106
Aug 6, 2026	RBC Capital	Shagun Singh	PT Raise	Outperform	$101→$110
Aug 6, 2026	Bernstein	Lee Hambright	PT Raise	Market Perform	$91→$93
Aug 6, 2026	Stifel	Rick Wise	PT Raise	Buy	$105→$110
Jul 28, 2026	UBS	Patrick Wood	Assumes	Sell→Buy	$89→$115
Jul 9, 2026	BMO Capital	Vik Chopra	Initiate	Outperform→Market Perform	$95
Jul 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$120→$110
May 28, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$95→$93
Apr 29, 2026	JP Morgan	Robbie Marcus	PT Cut	Neutral	$100→$95
Apr 29, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$98→$95
Apr 29, 2026	Citizens	David Turkaly	PT Cut	Market Outperform	$120→$105
Apr 29, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$98→$90
Apr 29, 2026	Barclays	Matt Miksic	PT Cut	Underweight	$100→$94
Apr 29, 2026	Truist Securities	Richard Newitter	PT Cut	Hold	$98→$92
Apr 29, 2026	Stifel	Rick Wise	PT Cut	Buy	$110→$105
Apr 13, 2026	Leerink Partners	Mike Kratky	Initiate	Market Perform	$101
Mar 23, 2026	BTIG	Ryan Zimmerman	Downgrade	Buy→Neutral	—

Analyst Ratings News

PRO
Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target

Argus Research analyst David Toung reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and maintains $125 price target.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

Barclays analyst Christopher Pasquale initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight rating and announces Price Target of $100.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.

Benzinga Newsdesk

PRO
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.

Benzinga Newsdesk

Zimmer Biomet Holdings Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Zimmer Biomet Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target

PRO
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

PRO
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

PRO
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

PRO
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

PRO
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

People Also Watch

People Also Watch

Zimmer Biomet Holdings Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Zimmer Biomet Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROArgus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target

PROBarclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

PROCanaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

PROTruist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

PRORBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

PROBernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

People Also Watch

People Also Watch

PRO
Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target

PRO
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

PRO
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

PRO
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

PRO
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

PRO
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93